Literature DB >> 30466846

Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.

Seung-Jung Park1, James L Gentry2, Niraj Varma2, Oussama Wazni2, Khaldoun G Tarakji2, Anand Mehta3, Stephanie Mick4, Richard Grimm2, Bruce L Wilkoff5.   

Abstract

OBJECTIVES: The aims of this study were to detect and quantify acute increases in tricuspid regurgitation (TR) severity following transvenous lead extraction (TLE) and to evaluate the associated risk factors.
BACKGROUND: Although established as a safe and effective method for lead removal, TLE is sometimes complicated by TR.
METHODS: In 208 consecutive patients undergoing TLE, acute changes in TR severity were assessed by transesophageal echocardiography. A significant acute TR increase (TRI) was defined as a ≥1 grade increase in TR severity and post-extraction TR severity that was moderate or greater.
RESULTS: Overall, 266 ventricular leads (mean lead age, 11.8 ± 7.3 years) were extracted from the 208 patients. A significant acute TRI was observed in 24 (11.5%) of these patients. Acute TRI was associated with longer lead implant duration, extraction of pacemaker rather than defibrillator leads, anatomic injury to the tricuspid valve (TV), and longer post-extraction hospital stays. Multivariate analysis yielded only lead implant duration as an independent predictor of TLE-related acute TRI (odds ratio: 1.05; 95% confidence interval: 1.01 to 1.11; p = 0.046). When the patients were divided into 4 subgroups according to quartiles of lead age, there was a graded elevation in the rates of acute TRI (p trend = 0.048) and TV injury (p trend = 0.009) with lead implant duration.
CONCLUSIONS: Following TLE, TV damage and acute TRI were commonly detected by transesophageal echocardiography, particularly in patients with advanced lead age. Lead abandonment strategies, which prolong implantation duration of future leads requiring extraction, should consider the potential long-term deleterious impact on TV function.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  extraction; implantable cardioverter-defibrillator; lead; pacemaker; tricuspid regurgitation

Mesh:

Year:  2018        PMID: 30466846     DOI: 10.1016/j.jacep.2018.07.011

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  9 in total

1.  Anaesthesia for extraction of long-term cardiac device leads.

Authors:  A Martin; B De Bie; J O'Loughlin
Journal:  BJA Educ       Date:  2022-05-11

2.  The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Andrzej Kleinrok; Łukasz Tułecki; Andrzej Kutarski
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

3.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

4.  Multiplane/3D transesophageal echocardiography monitoring to improve the safety and outcome of complex transvenous lead extractions.

Authors:  Mihai Strachinaru; Chris M Kievit; Sing C Yap; Alexander Hirsch; Marcel L Geleijnse; Tamas Szili-Torok
Journal:  Echocardiography       Date:  2019-03-24       Impact factor: 1.724

5.  Transvenous lead extraction using the TightRail mechanical rotating dilator sheath for Asian patients.

Authors:  Ji-Hoon Choi; Seung-Jung Park; Hye Ree Kim; Hee-Jin Kwon; Kyoung-Min Park; Young Keun On; June Soo Kim; Ju Youn Kim; Won Young Jung
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

6.  Analysis of Risk Factors for Major Complications of 1500 Transvenous Lead Extraction Procedures with Especial Attention to Tricuspid Valve Damage.

Authors:  Łukasz Tułecki; Anna Polewczyk; Wojciech Jacheć; Dorota Nowosielecka; Konrad Tomków; Paweł Stefańczyk; Jarosław Kosior; Krzysztof Duda; Maciej Polewczyk; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2021-08-28       Impact factor: 3.390

7.  Novel atrioventricular sequential pacing approach using a transvenous atrial pacemaker and a leadless pacemaker: a case report.

Authors:  Elhosseyn Guella; Frances Devereux; Fozia Zahir Ahmed; Peter Scott; Colin Cunnington; Amir Zaidi
Journal:  Eur Heart J Case Rep       Date:  2021-07-19

8.  Tricuspid Valve Damage Related to Transvenous Lead Extraction.

Authors:  Anna Polewczyk; Wojciech Jacheć; Dorota Nowosielecka; Andrzej Tomaszewski; Wojciech Brzozowski; Dorota Szczęśniak-Stańczyk; Krzysztof Duda; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

9.  Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure.

Authors:  Felix Hedwig; Olena Nemchyna; Julia Stein; Christoph Knosalla; Nicolas Merke; Fabian Knebel; Andreas Hagendorff; Felix Schoenrath; Volkmar Falk; Jan Knierim
Journal:  Front Cardiovasc Med       Date:  2021-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.